The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its exclusivity period created a deluge of lower-priced alternatives , significantly eroding its market share . While certain firms may attempt to capitalize on similar conditions , the